SP-MHCI-0344-3

SARS-CoV-2 Replicase polyprotein 1a 4140-4149, CTDDNALAYY

US$507.00

In stock

Description

About SARS-CoV-2 Replicase polyprotein 1a 4140-4149, CTDDNALAYY

The SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) Replicase polyprotein 1a Peptide (IEDB: 7122) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Replicase polyprotein Peptide, H-CTDDNALAYY-OH (Uniprot: P0C6U8 aa: 4140-4149) from JPT is produced under strict quality control and quality management.

SARS-CoV-2 Replicase polyprotein 1a 4140-4149, CTDDNALAYY - Specifications

  • Peptide sequence: H-CTDDNALAYY-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Covid-19
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for SARS-CoV-2 Replicase polyprotein 1a 4140-4149, CTDDNALAYY

References:
Read References with JPT’s Antigen Peptides
SARS-CoV-2 Replicase polyprotein 1a 4140-4149, CTDDNALAYY has been described in:
Unbiased Screens Show CD8<sup>+</sup> T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein., Immunity, 2020 (PMID: 33128877)
Characterization of pre-existing and induced SARS-CoV-2-specific CD8<sup>+</sup> T cells., Nat Med, 2021 (PMID: 33184509)
Constitutive and inflammatory immunopeptidome of pancreatic β-cells., Diabetes, 2012 (PMID: 22872234)

Documentation

Documentation for SARS-CoV-2 Replicase polyprotein 1a 4140-4149, CTDDNALAYY

Properties

Properties of SARS-CoV-2 Replicase polyprotein 1a 4140-4149, CTDDNALAYY

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Covid-19
Layout: Freeze-dried in glass vial
Organism: SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Protein Name: Replicase polyprotein
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to SARS-CoV-2 Replicase polyprotein 1a 4140-4149, CTDDNALAYY

Information Values
Sequence: H-CTDDNALAYY-OH
Specifications: 10mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote